Surgical resection for gastric cancer patients with liver metastasis
10.3760/cma.j.issn.0253-3766.2017.07.011
- VernacularTitle: 胃癌肝转移的手术疗效及影响因素
- Author:
Yingjun LIU
1
;
Gangcheng WANG
1
;
Xiangbin WAN
1
;
Yong CHENG
1
;
Youcai WANG
1
;
Xiaoyong LIU
1
;
Guangsen HAN
1
Author Information
1. Department of General Surgery, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China
- Publication Type:Clinical Trail
- Keywords:
Stomach neoplasms;
Neoplasm metastasis;
Liver metastasis;
Gastrectomy
- From:
Chinese Journal of Oncology
2017;39(7):532-535
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the surgical results and clinicopathological features of gastric cancer patients with liver metastases.
Methods:The clinicopathological data and post-operative survival of 37 patients who underwent resection of liver metastasis from gastric cancer at our department from Dec. 2007 to Dec. 2014 were analyzed.
Results:The 1-, 3-, and 5-year overall survival rates after resection were 91.4%, 57.9%, and 22.0%, respectively, with a median survival of 37 months. Univariate analysis revealed that lymph node metastasis, multiple hepatic metastases and no preoperative chemotherapy are unfavorable prognostic factors for overall survival. Multivariate analysis identified that lymph node metastasis and number of liver metastasis are independent prognostic factors.
Conclusions:Gastric cancer patients with a solitary liver metastasis may be good candidates for gastric D2 resection combined with liver R0 resection.
